Clinical Trials on Peripheral Edema in Belgium

Total 273 results

Sanofi
Bristol-Myers Squibb

Completed

CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease

Arterial Occlusive Diseases

France, Spain, Italy, Belgium, Germany, Hungary, Poland, Australia, Austria, Netherlands, Sweden, United Kingdom, Finland, Switzerland
Ziekenhuis Oost-Limburg

Completed

Pulsed Radiofrequency Treatment Of the Gasserian Ganglion for tRigeminal nEuralgia: a retroSpective Study (Progress)

Trigeminal Neuralgia (TN)

Belgium
Pfizer

Completed

Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain

Neuropathic Pain

Belgium, Austria, United Kingdom, France
Cordis Corporation
Massachusetts General Hospital; Prairie Education and Research Cooperative

Completed

Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (OPEN)

Cardiovascular Diseases | Peripheral Vascular Disease | Peripheral Artery Disease | Vascular Disease | PAD

United States, Belgium
Biotronik AG

Completed

BIOLUX P-III All-Comers Passeo-18 Lux Registry

Atherosclerosis | Peripheral Artery Disease

France, Germany, Spain, Belgium, Singapore, Austria, Netherlands, Malaysia, Italy, Switzerland, Denmark, Portugal, Australia, Finland, Latvia, Slovakia
Universitair Ziekenhuis Brussel

Recruiting

The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study (TONIC)

Covid19 | Peripheral Blood Mononuclear Cells | Complement Abnormality

Belgium
Erasmus Medical Center
Universitaire Ziekenhuizen KU Leuven; ZonMw: The Netherlands Organisation for... and other collaborators

Terminated

Effect of Lamotrigine on Cognition in NF1 (NF1-EXCEL)

Neurofibromatosis Type 1

Spain, Belgium, Netherlands
iVascular S.L.U.

Not yet recruiting

Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease (ILICO)

Peripheral Arterial Disease | Iliac Artery Disease | Angioplasty | Aorto-Iliac Atherosclerosis | Covered Stent

Belgium, Germany, France, Spain
Sanofi

Completed

Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication (TALISMAN 211)

Peripheral Arterial Occlusive Disease

United States, Belgium, Germany, Switzerland
Spirecut
Archer Research

Completed

Clinical Investigation on Safety, Performance and Effectiveness of Sono-instruments (SONO-01)

Carpal Tunnel Syndrome | Trigger Finger | Trigger Thumb

Belgium
KU Leuven

Active, not recruiting

Assessment of Subsynovial Connective Tissue Thickness in Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

Belgium
University Hospital, Antwerp

Terminated

Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment (PELICAN)

Neuropathic Pain

Belgium
University Hospital, Ghent
General Hospital Groeninge; Anglia Ruskin University; KU Leuven Campus Kulak...

Withdrawn

Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients. (stREnGTH)

Head Neck Cancer | Pain, Neuropathic | Radiation Neuropathy

Belgium
The Lymphoma Academic Research Organisation

Completed

Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine

Refractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma

France, Belgium
Jessa Hospital

Completed

COVID-19 and Deep Venous Thrombosis

COVID-19 | Deep Vein Thrombosis (DVT)/Thrombophlebitis

Belgium
W.L.Gore & Associates

Recruiting

Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry

Trauma Injury | Peripheral Artery Disease | Hemodialysis Access | Popliteal Aneurysm | Visceral Artery Aneurysms

Spain, Italy, Germany, Sweden, Netherlands, United Kingdom, France, Belgium, Greece
Centre Hospitalier Universitaire Saint Pierre
Université Libre de Bruxelles

Withdrawn

Study on the Efficacy of Infiltration of Upper Cluneal Nerves in Chronic Pain Related to Cluneal Syndrome

Nerve Entrapment Syndrome | Cluneal Syndrome

Belgium
Medtronic Endovascular

Completed

IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA

Peripheral Arterial Disease | Critical Limb Ischemia

Switzerland, Belgium, France, Greece, Italy
Université Libre de Bruxelles

Unknown

Ultrasound-guided Lumbar Periradicular Injection: a Non Irradiating Infiltration Technique

Low Back Pain | Sciatica | Chronic Low Back Pain | Pain, Chronic | Disc, Herniated | Foraminal Hernia | Lumbar Foraminal Stenosis | Injection Site Infiltration

Belgium
SurModics, Inc.

Active, not recruiting

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND)

Peripheral Arterial Disease | Peripheral Vascular Disease | Femoropopliteal Artery Occlusion | Artery Disease, Peripheral

New Zealand, United States, Belgium, Latvia, Germany, Australia, Austria, Czechia, Italy
Spectranetics Corporation

Completed

STELLAREX: ILLUMENATE Global and In-Stent Restenosis (ISR) (ILLUMENATE)

Peripheral Arterial Disease

Belgium, Germany, New Zealand, France, United Kingdom, Australia, Poland, Austria, Italy, Spain
Cliniques universitaires Saint-Luc- Université...
Université Catholique de Louvain

Active, not recruiting

Prognostic Factors for Complex Regional Pain Syndrome (CRPSPrognosis)

Complex Regional Pain Syndromes

Belgium
C. R. Bard

Completed

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Peripheral Artery Disease

United States, Germany, Belgium, Austria, Switzerland
Boston Scientific Corporation

Completed

RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA)

Atherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial Disease

United States, Belgium, Canada, Japan, Austria, New Zealand
Sanofi

Completed

Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials (TALISMAN S)

Peripheral Arterial Occlusive Disease

United States, France, Germany, Italy, Switzerland, Belgium, United Kingdom
KU Leuven

Not yet recruiting

The Use of a Monitoring Device by General Practitioners During Out-of-hours Care

Heart Failure | Pneumonia | Pneumothorax | Emergencies | Atrial Fibrillation | Asthma | Hyperventilation | Acute Coronary Syndrome | Cardiac Arrest | Atrial Flutter | Pulmonary Embolism | Acute Myocardial Infarction | Pulmonary Edema | Rhythm; Abnormal | Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Belgium
Astellas Pharma Europe Ltd.

Completed

A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment (ELEVATE)

Non-diabetic Painful Peripheral Polyneuropathy | Postherpetic Neuralgia (PHN) | Peripheral Nerve Injury (PNI)

Armenia, Austria, Belarus, Belgium, Bulgaria, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Poland, Portugal, Romania, Russian Federation, Slovakia, Slovenia, Spain, Sweden, Turkey, United Kingdom
University of Aarhus
Odense University Hospital; Aarhus University Hospital; CHU de Quebec-Universite... and other collaborators

Completed

Examining Carryover Effect in Patients Treated witH Spinal cOrd Stimulation (ECHO) (ECHO)

Neuralgia | Spinal Cord Stimulation

Denmark, Sweden, Belgium, Canada, Germany, Netherlands
Becton, Dickinson and Company
FGK Clinical Research GmbH

Completed

Prospective Observational Study of the Power PICC Family of Devices and Accessories

Peripherally Inserted Central Catheter

Germany, Czechia, Austria, Belgium, Denmark, Italy, Netherlands, Spain, Switzerland
Remedy Pharmaceuticals, Inc.

Terminated

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction (CHARM)

Stroke, Acute | Brain Edema

United States, Spain, China, Italy, United Kingdom, Germany, Australia, Hungary, Taiwan, Israel, Canada, Portugal, Korea, Republic of, Czechia, Brazil, Switzerland, France, Belgium, Japan, Lithuania, Croatia, Denmark, Finland, Russian...
Astellas Pharma Inc

Completed

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients (PACE)

Painful Diabetic Peripheral Neuropathy (PDPN)

Belgium, Czech Republic, France, Germany, Italy, Netherlands, Poland, Russian Federation, Spain, Ukraine, United Kingdom
Spectranetics Corporation

Completed

Stellarex Vascular E-Registry (SAVER)

Peripheral Arterial Disease

Belgium, Germany, France, United Kingdom, Austria, Italy
Algiax Pharmaceuticals GmbH
FGK Clinical Research GmbH

Recruiting

AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain

Peripheral Post-surgical Neuropathic Pain

Czechia, Germany, Spain, Belgium, France
Sanofi

Completed

Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions (TAMARIS)

Peripheral Vascular Diseases

France, Canada, Brazil, Poland, Russian Federation, Ukraine, Germany, Spain, Sweden, Switzerland, United States, Turkey, Singapore, Belgium, Czech Republic, Mexico, Japan, Austria, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chil... and more
MedtronicNeuro

Terminated

CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain

Facial Pain | Pain, Intractable

Austria, Germany, Belgium, Spain
Daiichi Sankyo, Inc.
UMC Utrecht

Completed

Edoxaban in Peripheral Arterial Disease (ePAD)

Peripheral Arterial Disease

United States, Germany, Switzerland, Israel, Netherlands, Austria, Belgium
Laurent Servais
SYSNAV

Recruiting

Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study

Duchenne Muscular Dystrophy | Myotonic Dystrophy 1 | Congenital Muscular Dystrophy | Centronuclear Myopathy | Charcot-Marie-Tooth | Fascioscapulohumeral Muscular Dystrophy

Belgium
Medtronic Endovascular

Completed

IN.PACT Global Clinical Study

Peripheral Arterial Disease

Korea, Republic of, Belgium, Germany, Hungary, Singapore, Canada, Austria, United Kingdom, Australia, Argentina, Netherlands, Italy, Slovenia, Colombia, Czechia, Egypt, Finland, France, Greece, Israel, Lithuania, Poland, Portugal, Russian... and more
Spectranetics Corporation
Philips Healthcare

Suspended

Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries (ILLUMENATE-BTK)

Critical Limb Ischemia

United States, Belgium, Australia, Germany, Austria
Egetis Therapeutics
Solasia Pharma K.K.

Terminated

Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer (POLAR-A)

Colorectal Cancer | Chemotherapy-induced Peripheral Neuropathy

France, Korea, Republic of, Italy, Japan, Spain, Belgium, Germany, United Kingdom, Czechia, Taiwan
Eli Lilly and Company

Completed

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

Leiomyosarcoma | Rhabdomyosarcoma | Synovial Sarcoma | Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET) | Adipocytic Sarcoma

United States, Germany, Poland, Belgium, Spain, France, Netherlands
Medtronic Spinal and Biologics

Completed

Herniectomy Versus Herniectomy With a Spinal Stabilization System for the Treatment of Complex Disc Disease

Back Pain | Sciatica

Switzerland, Belgium, Czech Republic, Germany, Italy, Poland, Spain, United Kingdom
The Lymphoma Academic Research Organisation
Innate Pharma

Recruiting

Study of Lacutamab in Peripheral T-cell Lymphoma

Peripheral T Cell Lymphoma | Relapse/Recurrence

France, Spain, Belgium, Germany
Millennium Pharmaceuticals, Inc.

Completed

Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma

Refractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma

United States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
University of Birmingham
Roche Pharma AG; Cancer Research UK; Imagine for Margo; EUSA Pharma, Inc.

Active, not recruiting

Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children (BEACON)

Neuroblastoma

France, Austria, Belgium, Denmark, Ireland, Italy, Spain, Switzerland, United Kingdom, Netherlands
Bayer
Janssen Research & Development, LLC; Colorado Prevention Center

Completed

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities (VOYAGER PAD)

Peripheral Artery Disease

Poland, Belgium, France, Spain, China, Korea, Republic of, United States, Switzerland, Estonia, Portugal, Japan, Hungary, Canada, Netherlands, Finland, Austria, United Kingdom, Germany, Czechia, Thailand, Brazil, Denmark, Italy, Russian... and more
Gesynta Pharma AB
Ergomed

Completed

A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis

Systemic Sclerosis

United Kingdom, Poland, Belgium, Netherlands
Egetis Therapeutics
Solasia Pharma K.K.

Terminated

Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) (POLAR-M)

Colorectal Cancer | Chemotherapy-induced Peripheral Neuropathy

France, Korea, Republic of, United States, Italy, United Kingdom, Hong Kong, Spain, Hungary, Belgium, Japan, Germany, Czechia, Taiwan
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PROPEL)

Peripheral T-cell Lymphoma

United States, United Kingdom, Canada, France, Italy, Belgium
European Infant Neuroblastoma Study Group - 1999

Completed

Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.

Neuroblastoma

Switzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom

Clinical Trials on Peripheral Edema in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations